CN115721586B

CN115721586B - Skin care matrix

Info

Publication number: CN115721586B
Application number: CN202211076768.8A
Authority: CN
Inventors: 孙怀庆; 聂艳峰; 叶海莲; 蒲艳; 王娟; 胡露
Original assignee: Guangdong Marubi Biological Technology Co Ltd
Current assignee: Guangdong Marubi Biological Technology Co Ltd
Priority date: 2022-09-05
Filing date: 2022-09-05
Publication date: 2023-09-15
Anticipated expiration: 2042-09-05
Also published as: CN115721586A

Abstract

The application relates to the field of cosmetics, and relates to a skin care matrix, which comprises the following components: emulsifiers, moisturizers, oils and skin conditioners excluding alcohol, colorants, hormones, mineral oil, silicone oil, parabens and formaldehyde-releasing preservatives; skin conditioning agents include: prinsepia utilis royle oil, prinsepia utilis royle fermented extract, panthenol, phytosothes LS9766, symRelief100. The formula is extremely simple, safe, effective, mild and non-irritating, and is suitable for sensitive skin and common children skin. The skin moisturizing agent has the advantages of good moisturizing effect, obvious reduction of skin moisture loss while providing skin moisture for children, excellent moisturizing and water locking effects, and capability of relieving the damage to the skin caused by external stimulus and reducing skin inflammation and redness. After the skin care cream is used, the skin moisture can be obviously improved, the skin percutaneous moisture loss rate can be reduced, the skin discomfort can be relieved, the conditions of skin dryness, skin peeling and skin allergy can be reduced, and the skin is tender and healthy.

Description

Skin care matrix

Technical Field

The application relates to the field of cosmetics, in particular to a skin care matrix.

Background

The skin of infants is significantly different from that of adults, from a structural point of view: the skin of infants and children has the thickness of only one tenth of that of the skin of adults, the dermis and the fibrous tissues are thinner, and the water content of the epidermis is far higher than that of adults. From the function, the skin difference between the infant skin and the adult skin is more obvious, the external harmful substances are easy to be absorbed, and the reaction to allergic substances or toxic substances is stronger; weak skin barrier function, weak resistance, and easy skin allergy or inflammation; skin moisture is easy to run off, and skin dryness, peeling and chapping are easy to occur; the pigment layer of the skin is thin, the ultraviolet resistance is extremely poor, and the skin is easily damaged by ultraviolet rays.

The living mode of the infant is greatly different from that of the adult, and the infant is specifically expressed as follows: the skin of the infant part area is often covered by the diaper, excrement is often contacted, the cleaning frequency is high, and the skin barrier of the diaper area is more easily damaged; the frequency of the activities of children is higher, the cognition on dangers is poor, and the skin is easier to deviate from the normal physiological state; in addition, children prefer a touch search of the environment, which also increases the chance of skin injury or infection.

At present, the quality of the children cosmetics is uneven, the total number of detected bacterial colonies or the standard of mould saccharomycetes is exceeded, and the products are frequently and frequently subjected to the safety problems of products such as dioxane or asbestos, the content of the dioxane or asbestos does not reach the standard, and the like.

Some other children cosmetics cannot improve the skin moisture and have poor relieving effect.

Disclosure of Invention

It is an aim of embodiments of the present application to provide a skin care matrix.

The present application provides a skin care matrix comprising: emulsifying agents, moisturizers, greases, and skin conditioners; the skin care matrix does not include alcohols, colorants, hormones, mineral oils, silicone oils, parabens and formaldehyde-releasing preservatives;

skin conditioning agents include:

prinsepia utilis oil, prinsepia utilis fermentation extract, panthenol, phytosothes LS9766 and SymReelief 100.

The skin care matrix provided by the application has the advantages of extremely simple, safe and effective formula, mildness and no stimulation, and is suitable for children with sensitive skin and common skin. Furthermore, the skin care matrix has good moisturizing effect, can obviously reduce the water loss of the skin while providing the skin moisture for children, has good moisturizing and water locking effects, can well relieve the damage of external stimulus to the skin, and reduces the skin inflammation and redness. The skin care matrix provided by the application is a skin conditioner consisting of prinsepia utilis royle oil, prinsepia utilis royle fermentation extract, panthenol, phytochoside LS9766 and SymRelief100, and can obviously improve skin moisture after use, reduce skin percutaneous moisture loss rate, relieve skin discomfort, reduce skin dryness, desquamation and allergy, and enable skin to be tender and healthy.

In other embodiments of the present application, the skin conditioning agent comprises, in parts by weight: 0.01 to 5 percent of prinsepia utilis royle oil, 0.01 to 10 percent of prinsepia utilis royle fermentation extract, 0.01 to 5 percent of panthenol, 0.01 to 8 percent of phytoooth LS9766 and 100.01 to 0.3 percent of SymRelief.

In other embodiments of the application, the prinsepia utilis royle fermented extract comprises: glycerol, yeast fermentation product extract, prinsepia utilis royle seed extract.

In other embodiments of the application, the phytosophy LS9766 comprises: brassinosteroids, cetostearyl alcohol.

In other embodiments of the application, symRelief100 comprises: bisabolol, ginger root extract.

In other embodiments of the application, the emulsifier is selected from naturally derived emulsifiers;

the grease is selected from natural source grease;

the humectant is a natural humectant.

In other embodiments of the application, the naturally derived emulsifiers include: at least one of C12-20 alkyl glucoside, coco glucoside, cetostearyl glucoside, arachidyl glucoside, C20-22 alcohol phosphate, sucrose monostearate, cetyl palmitate, sodium stearyl glutamate, glyceryl stearate citrate, or polyglycerol-3 methyl glucose distearate.

In other embodiments of the application, the naturally derived grease comprises: at least one of caprylic/capric triglyceride, ethylhexyl palmitate, dioctyl carbonate, oleyl erucate, decyl cocoate, sunflower seed oil, butylene glycol dicaprylate/dicaprate, jojoba seed oil, olive oil, squalane, prinsepia utilis, C13-16 isoparaffin, undecane, tridecane, decyl oleate, coco glyceride, coco-caprylate/caprate, octyl dodecanol myristate, pink passion fruit oil, brassica sterols, cetostearyl alcohol, tallow, myristyl alcohol myristate, cetyl palmitate, or hydrogenated vegetable oil glycerides.

In other embodiments of the application, the naturally derived moisturizer comprises: at least one of organic glycerin, 1, 3-propanediol, xylitol-based glucoside, dehydrated xylitol, betaine, amino acid humectant, trehalose or algae extract.

In other embodiments of the present application, the amount of emulsifier added to the skin care matrix is 0.1% -8% by mass, the amount of humectant added is 2% -25% by mass, and the amount of grease added is 1% -40% by mass.

Drawings

In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings that are needed in the embodiments will be briefly described below, it being understood that the following drawings only illustrate some embodiments of the present application and therefore should not be considered as limiting the scope, and other related drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.

FIG. 1 shows the results of test for inhibition of neutrophil aggregation in zebra fish embryos of examples and comparative examples of the present application.

Detailed Description

For the purpose of making the objects, technical solutions and advantages of the embodiments of the present application more apparent, the technical solutions in the embodiments of the present application will be clearly and completely described below, and it is apparent that the described embodiments are some embodiments of the present application, but not all embodiments.

Thus, the following detailed description of the embodiments of the application is not intended to limit the scope of the application, as claimed, but is merely representative of selected embodiments of the application. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.

Embodiments of the present application provide a skin care matrix comprising: emulsifying agents, moisturizers, greases, and skin conditioners; the skin care matrix does not include alcohols, colorants, hormones, mineral oils, silicone oils, parabens and formaldehyde-releasing preservatives;

skin conditioning agents include:

The skin conditioner is compounded by four components of prinsepia utilis royle oil, prinsepia utilis royle fermented extract, panthenol, phytochoside LS9766 and SymRelief100, and the four components are synergistic, so that the relieving effect is greatly improved. For the above four components, if one of them is arbitrarily selected or two or three of them are arbitrarily selected, the effect of relaxation is reduced. Further optionally, in some embodiments of the present application, the skin conditioning agent comprises, in parts by weight: 0.01 to 5 percent of prinsepia utilis royle oil, 0.01 to 10 percent of prinsepia utilis royle fermentation extract, 0.01 to 5 percent of panthenol, 0.01 to 8 percent of phytoooth LS9766 and 100.01 to 0.3 percent of SymRelief.

The inventor finds that the optimal range of the soothing effect can be achieved by compounding the four components of prinsepia utilis royle oil, prinsepia utilis royle fermented extract, panthenol, phytochoside LS9766 and SymRelief100 according to the proportion.

Further, in some embodiments of the present application, the skin conditioning agent comprises, in parts by weight: 0.02% -4.9% of prinsepia utilis royle oil, 0.02% -9.9% of prinsepia utilis royle fermentation extract, 0.02% -9.9% of panthenol, 0.02% -7.9% of phytooothey LS9766 and 1000.02% -0.29% of SymReelief.

Further, in some embodiments of the present application, the skin conditioning agent comprises, in parts by weight: 0.05 to 4.5 percent of prinsepia utilis royle oil, 0.05 to 9.5 percent of prinsepia utilis royle fermentation extract, 0.05 to 9.5 percent of panthenol, 0.05 to 7.5 percent of phytooothey LS9766 and 1000.05 to 0.25 percent of SymRelief.

Illustratively, the skin conditioning agent comprises, in parts by mass: 0.1%, 1%, 1.5%, 1.8%, 2.5%, 3%, 3.5% or 4% of prinsepia utilis royle oil; 0.05%, 0.1%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8% or 9% of a fermentation extract of Prinsepia utilis royle; panthenol 0.1%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8% or 9%; phytosophy LS 97660.1%, 1%, 2%, 3%, 4%, 5%, 6%, 6.5% or 7%; symRelief 1000.06%, 0.08%, 0.09%, 0.10%, 0.12%, 0.15%, 0.18%, 0.20%, 0.23%, or 0.24%.

Further, in some embodiments of the application, the prinsepia utilis royle fermented extract comprises: glycerol, yeast fermentation product extract, prinsepia utilis royle seed extract.

Further, in some embodiments of the application, the phytoooth LS9766 comprises: brassinosteroids, cetostearyl alcohol.

Further, in some embodiments of the application, symRelief100 comprises: bisabolol, ginger root extract.

Further, in some embodiments of the application, the prinsepia utilis royle oil producer is astragal.

Further, in some embodiments of the application, the prinsepia utilis royle fermented extract manufacturer is astragalin.

Further, in some embodiments of the present application, the panthenol described above is produced by DSM.

Further, in some embodiments of the application, the above-described phytosophy LS9766 is provided by Basoff.

Further, in some embodiments of the present application, the SymRelief100 is manufactured by Dexin.

Further, in some embodiments of the application, the emulsifier is selected from naturally derived emulsifiers;

the grease is selected from natural source grease;

the humectant is a natural humectant.

Further, in some embodiments of the application, the naturally derived emulsifier comprises: at least one of C12-20 alkyl glucoside, coco glucoside, cetostearyl glucoside, arachidyl glucoside, C20-22 alcohol phosphate, sucrose monostearate, cetyl palmitate, sodium stearyl glutamate, glyceryl stearate citrate, or polyglycerol-3 methyl glucose distearate.

Further, in some embodiments of the application, the naturally derived grease comprises: at least one of caprylic/capric triglyceride, ethylhexyl palmitate, dioctyl carbonate, oleyl erucate, decyl cocoate, sunflower seed oil, butylene glycol dicaprylate/dicaprate, jojoba seed oil, olive oil, squalane, prinsepia utilis, C13-16 isoparaffin, undecane, tridecane, decyl oleate, coco glyceride, coco-caprylate/caprate, octyl dodecanol myristate, pink passion fruit oil, brassica sterols, cetostearyl alcohol, tallow, myristyl alcohol myristate, cetyl palmitate, or hydrogenated vegetable oil glycerides.

Further, in some embodiments of the application, the natural source moisturizer comprises: at least one of organic glycerin, 1, 3-propanediol, xylitol-based glucoside, dehydrated xylitol, betaine, amino acid humectant, trehalose or algae extract.

Further, in some embodiments of the present application, the skin care matrix is added in an amount of 0.1% -8% by mass, the moisturizer is added in an amount of 2% -25% by mass, and the grease is added in an amount of 1% -40% by mass.

Further alternatively, in some embodiments of the present application, the skin care matrix is added in an amount of 0.2% -7.9% by mass, the humectant is added in an amount of 2.5% -24% by mass, and the grease is added in an amount of 1.5% -39% by mass.

Illustratively, the amount of emulsifier added to the skin care matrix is 0.5%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%, 6.5%, 7% or 7.5% by mass. The humectant is added in an amount of 2.5%, 3%, 3.5%, 4%, 5%, 8%, 10%, 12%, 15%, 18%, 20% or 23%. The amount of the oil or fat added was 1.5%, 4%, 8%, 10%, 15%, 20%, 25%, 30%, 35% or 38%.

Further, in some embodiments of the present application, the skin care matrix described above may optionally further include chelating agents, skin conditioning agents, emollients, thickeners, preservatives, fragrances commonly used in cosmetics.

In some embodiments of the application, the skin care matrix consists of the following ingredients: deionized water, REFINED GLYCERIN (organic glycerin),OSMS BA (betaine), D-Panthenol,980POLYMER, p-hydroxyacetophenone, 1, 2-hexanediol, TEGO Care 450MB (polyglycerol-3-methylglucdistearate), and->372P (glycerol stearate citrate), tocopheryl acetate, prinsepia utilis royle oil, caprylic/capric triglyceride, < ->LS9766, AMP-ULTRA PC 2000,Neutralizing Amine (aminomethylpropanol, water), ->100. Prinsepia utilis royle fermented extract.

Further, in some embodiments of the application, the total fraction of skin care matrix is 100 parts by mass. Wherein REFINED GLYCERIN (organic glycerin) is 5-15,OSMS BA (betaine) 1-5, D-Panthenol (Panthenol) 0.1-5, < ->980POLYMER (carbomer) 0.1-0.5, p-hydroxyacetophenone 0.1-1, 2-hexanediol 0.1-1, TEGO Care 450MB (polyglycerol-3-methyl glucose distearate) 1-3,372P (glycerol stearate citrate) 0.5-2, tocopherol acetate 0.5-2, prinsepia utilis royle oil 0.1-5, caprylic/capric triglyceride 5-15, and->LS9766 0.1-8, AMP-ULTRA PC 2000,Neutralizing Amine (aminomethylpropanol, water) 0.1-0.5, +.>1000.05-0.3, and Prinsepia utilis royle fermented extract 0.1-10; the balance of deionized water.

Further alternatively, in some embodiments of the application, the total fraction of skin care matrix is 100 parts by mass. Wherein REFINED GLYCERIN (organic glycerin) is 7-13,OSMS BA (betaine) 1.5-4, D-Panthenol (Panthenol) 0.1-5,/L>980POLYMER 0.15-0.45, p-hydroxyacetophenone 0.2-0.9, 1, 2-hexanediol 0.2-0.9, TEGO Care 450MB (polyglycerol-3-methyl glucose distearate) 1.1-2.9,372P (glyceryl stearate citrate) 0.6-1.9, tocopherol acetate 0.6-1.9, prinsepia utilis royle oil 0.2-4.9, caprylic/capric triglycerideEsters 6-14>LS9766 0.1-8, AMP-ULTRA PC 2000,Neutralizing Amine (aminomethylpropanol, water) 0.11-0.45, +.>1000.05-0.3, and Prinsepia utilis royle fermented extract 0.1-10; the balance of deionized water.

The features and capabilities of the present application are described in further detail below in connection with the following examples:

examples 1 to 7 and comparative example 1

A skin care matrix is provided with the composition shown in Table 1. The preparation method comprises the following steps:

1. the raw materials with the serial numbers of 1-7 in the table 1 are put into a water phase pot, stirred and heated to 80-85 ℃, and stirred and dissolved uniformly to be uniform liquid.

2. The raw materials with the serial numbers of 8-13 in the table 1 are put into an oil phase pot, stirred and heated to 80-85 ℃, and stirred and dissolved uniformly.

3. And (3) pumping the water phase pot raw material into the emulsifying pot, starting rapid stirring at 63rpm, pumping the oil phase pot raw material in the step (2), and rapidly homogenizing at 3000rpm for 5min in an external circulation mode.

4. The raw material No. 14 in Table 1 was added and stirred uniformly, and the mixture was homogenized by inching and external circulation at 3000rpm for 15s.

5. Stirring to 40rpm, maintaining vacuum at (-0.05+ -0.01) MPa, stirring, cooling to (45+ -1) deg.C, adding the raw materials with the remaining serial numbers in table 1, and stirring.

5. Cooling to (38+/-1) deg.C, filtering and discharging.

In the preparation process, the pH value of the formula is controlled to be 6.0-7.0.

TABLE 1

The skin care matrix properties of examples 1-7 and comparative example 1 were tested.

1. Formulation mildness test

Skin closed patch test

Test article: for the samples of examples 1-7 and comparative example 1

A subject: the test was carried out on 32 subjects, 16 for men and women, aged 18-55 years, 10 for men, 22 for women, and 10 for 46-55 years.

The testing method comprises the following steps: the selected area is not more than 50mm ² A qualified plaque test apparatus with a depth of 1mm is used by adding the test object into the plaque tester with an amount of about 0.020g-0.025g. The plaque tester with the test substance and the negative control is applied to the forearm of the subject, the plaque tester is removed after 24 hours, the skin reaction is observed 30min, 24 hours, 48 hours after the removal of the plaque tester of the test substance, and the observation results are recorded.

The skin reaction criteria were observed as in table 2:

TABLE 2

Test results for the test substances are shown in Table 3:

TABLE 3 Table 3

The test results show that the score grades of the 32 subjects are 0 after 0.5h, 24h and 48h of the subject spot tester is removed, and adverse reactions are avoided.

2. Sensitive muscle suitability test

Test article: for the samples of examples 1-7 and comparative example 1

A subject:

1) Subjective assessment: the test subjects were asked for sensitivity to climate (cold or dry), skin care, detergent, textile and rough items, and scored separately, 0 for insensitivity, 1 for sometimes sensitivity, 2 for sensitivity, 5 scores were added, and the total score was greater than or equal to 4 scores for cream stinging screening.

2) Lactic acid stinging test: 50 μl of 10% lactic acid solution was dropped on 1 x 2cm nonwoven fabric, the nonwoven fabric was applied to the nasal labial sulcus of a subject at any time, and the other side was controlled with distilled water, and the testers interrogated the subjects for tingling sensation at 0.5, 2.5, 5, 8min, respectively, and scored according to the following table:

TABLE 4 Table 4

The accumulation of stinging feeling on the lactic acid side relative to the distilled water side is greater than or equal to 5, and the people are lactic acid stinging people, can be judged as sensitive muscles, are selected as sensitive muscle subjects, and the testers distribute the tested substances to the sensitive muscle subjects, and are divided into 8 groups of 32 people.

Trial test: the test subjects pick up the sample on the test day, test subjects on the face of the morning and evening, the testers follow up the phone 1 time a week, order the test subjects to fill in the use log, and refer to the skin response grading standard and the severity of adverse events of the human trial test. The subject is queried for adverse reactions and adverse events.

TABLE 5 skin reaction grading criteria for human trial

Rating scale of grade	Skin reaction
		0	Non-reaction
1	Weak erythema
		2	Erythema, infiltration, papule
3	Erythema, edema, papule, blister
		4	Erythema, edema, bulla

TABLE 6 severity of adverse events

Severity of disease	Judgment standard
		Mild and mild	The subject can tolerate the disease without special treatment and affecting the normal life of the subject
Moderate degree	The subjects are intolerable, and the products are required to be deactivated or specially treated, so that the normal life of the subjects is affected
		Heavy weight	Hamper normal life, require immediate product shutdown or emergency treatment

Table 7 if an adverse event occurs, the degree of correlation between the event and the test product is determined with reference to table 7.

TABLE 7

The test results are shown in Table 8:

TABLE 8

According to the test results, the skin response score of each group of 32 subjects was 0 in examples 1 to 7 after 4 weeks of use of the product, and no adverse reaction or adverse event occurred.

3. Efficacy evaluation

Product moisturizing and repairing efficacy evaluation

Test article: for the samples of examples 1-7 and comparative example 1

Brief description of the experiment: the water content of the stratum corneum of the application area (face) and the water loss rate of the skin through the surface are tested before the product is used and after 2h and 8h after the product is used, and the water content of the stratum corneum of the application area (face) and the water loss rate of the skin through the surface are tested after the product is continuously used for 28 days.

A subject: the subjects were divided into 8 groups of 20 persons each, with 3 men in each group, aged between 20 years and 60 years.

The test results are shown in Table 9:

TABLE 9

From the test results, it was found that the skin cuticle moisture content was increased after the test, wherein the increase in the value of comparative example 1 was the lowest, the increase in the values of examples 1 to 7 were all significantly higher than those of comparative example 1, the increase in the value of example 1 was the largest, the increase in the value of example 7 was several times, indicating that the moisturizing property of example 1 was the best among the test, the moisturizing property of example 7 was the next lowest, and the moisturizing property of comparative example 1 was the worst.

The skin transepidermal water loss rate was reduced after the test, with the lowest reduction in comparative example 1, the values reduced in examples 1-7 were all significantly greater than the reduction in comparative example 1, the greatest reduction in example 1, the lower value in example 7, indicating the best repair of example 1, the inferior repair of example 7, and the worst repair of comparative example 1.

4. Product soothing effect evaluation-test for inhibition of neutrophil aggregation of zebra fish embryo

Test article: for the samples of examples 1-7 and comparative example 1

The testing method comprises the following steps: and (3) testing by using a model of neutrophil aggregation caused by copper sulfate-induced nerve dome cell injury in the embryonic side line region of the zebra fish.

The test results are shown in FIG. 1: the samples of the blank, comparative example 1, and examples 1 to 7 are shown in the figure in this order from left to right.

From the test results shown in FIG. 1, the blank and comparative example 1 showed no significant inhibition of the number of neutrophils, and examples 1 to 7 showed the most potent inhibition of example 1, and example 7 times showed the best soothing effect of example 1 and the second most potent soothing effect of example 7 among the test subjects.

To sum up: from the analysis of the experimental data, the skin care matrix disclosed by the application is safe and mild, is suitable for sensitive skin, has obvious moisturizing, repairing and soothing effects, and is a safe and effective multifunctional skin care matrix.

The above description is only of the preferred embodiments of the present application and is not intended to limit the present application, but various modifications and variations can be made to the present application by those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included in the protection scope of the present application.

Claims

1. A skin care matrix, characterized in that the skin care matrix comprises: emulsifying agents, moisturizers, greases, and skin conditioners; the skin care matrix does not include alcohols, colorants, hormones, mineral oil, silicone oil, parabens and formaldehyde-releasing preservatives;

the skin conditioning agent comprises:

prinsepia utilis oil, prinsepia utilis fermentation extract, panthenol, phytosothes LS9766 and SymReelief 100;

the skin conditioning agent comprises the following components in percentage by mass: 2% -3% of prinsepia utilis royle oil, 1% -5% of prinsepia utilis royle fermentation extract, 1% -3% of panthenol, 1% -4% of phytochoside LS9766 and 100.01% -0.3% of SymRelief;

the prinsepia utilis royle fermentation extract comprises: glycerol, yeast fermentation product extract, prinsepia utilis royle seed extract;

the phytosophy LS9766 includes: brassinosteroids, cetostearyl alcohol;

the SymRelief100 comprises: bisabolol, ginger root extract.

2. The skin care matrix of claim 1, wherein,

the emulsifier is selected from natural sources;

the grease is selected from natural source grease;

the humectant is a humectant of natural origin.

3. The skin care matrix of claim 2, wherein,

the natural-source emulsifier comprises: at least one of C12-20 alkyl glucoside, coco glucoside, cetostearyl glucoside, arachidyl glucoside, C20-22 alcohol phosphate, sucrose monostearate, cetyl palmitate, sodium stearyl glutamate, glyceryl stearate citrate, or polyglycerol-3 methyl glucose distearate.

4. The skin care matrix of claim 2, wherein,

the natural source of grease includes: at least one of caprylic/capric triglyceride, ethylhexyl palmitate, dioctyl carbonate, oleyl erucate, decyl cocoate, sunflower seed oil, butylene glycol dicaprylate/dicaprate, jojoba seed oil, olive oil, squalane, prinsepia utilis, C13-16 isoparaffin, undecane, tridecane, decyl oleate, coco glyceride, coco-caprylate/caprate, octyl dodecanol myristate, pink passion fruit oil, brassica sterols, cetostearyl alcohol, tallow, myristyl alcohol myristate, cetyl palmitate, or hydrogenated vegetable oil glycerides.

5. The skin care matrix of claim 2, wherein,

the natural source moisturizer comprises: at least one of organic glycerin, 1, 3-propanediol, xylitol-based glucoside, dehydrated xylitol, betaine, amino acid humectant, trehalose or algae extract.

6. The skin care matrix of claim 2, wherein,

the skin care matrix comprises, by mass, 0.1% -8% of an emulsifier, 2% -25% of a humectant and 1% -40% of grease.